Bryon D Johnson, PhD

Children’s Wisconsin since 1989

Locations

Overview

Research Focus:

I am interested in understanding the biology and immunology of cancer, and uncovering novel immune-based approaches to treat cancer. My current research focuses on combining the following approaches to improve the use of cancer immunotherapy for treating both solid tumors and hematologic cancers: (1) immune checkpoint protein blockade, and (2) adoptive transfer of engineered cancer-reactive T lymphocytes.

Education and Awards

Education

  • 1983, Iowa State University, BS
  • 1992, Medical College of Wisconsin, Post Doctoral Fellow
  • 1989, The University of Health Sciences - The Chicago Medical School, PhD

Awards

  • 1999 Recipient of Best Abstracts Award, American Society for Blood and Marrow Transplantation (ASBMT) Annual Meeting, Miami Beach, FL
  • 2000 Ernest McCulloch and James Till Award for the best science article in Biology of Blood and Marrow Transplantation by a new investigator, American Society for Blood and Marrow Transplantation (ASBMT) Annual Meeting, Anaheim, CA
  • 2011 Teaching Award for contributions to the Medical Microbiology Course, Medical College of Wisconsin
  • 2013 Teaching Excellence Award for work in the Medical Student Physician Scientist Pathway, Medical College of Wisconsin

Editorship

  • 2010 – 2018 Associate Editor, Biology of Blood and Marrow Transplantation

Editorial Board

  • 2001 - Current Biology of Blood and Marrow Transplantation

Journal Review:

  • Biology of Blood and Marrow Transplantation
    Cellular Immunology
  • Haematologica
  • Journal of Clinical Investigation
  • Stem Cells
  • Clinical Immunology
  • Science Translational Medicine
  • Journal of Pediatric Hematology Oncology
  • Cancer Research
  • Disease Markers and Cancer Biomarkers
  • Clinical Cancer Research
  • Expert Reviews of Vaccines
  • Advances In Cancer Research
  • Immunology
  • Cancer Immunology Immunotherapy
  • Cytokine
  • Bone Marrow Transplantation
  • Blood

Journal of Immunotherapy


NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:

  •  1994 Grant Reviewer, The Israel Academy of Sciences and Humanities
  • 1997 - 1999 Grant Reviewer, Special Emphasis Panel, NIH
  • 1999 Grant Reviewer, Merit Review Award Program, VA
  • 2002 - 2003 Grant Reviewer, Special Panel, NIH
  • 2002 Member, Program Project Site Visits, NIH/NCI
  • 2002 - 2003 Abstract Reviewer, Coordinating Reviewer, Oral Abstract Session Co-Chair (2003), Annual Meeting, American Society of Hematology
  • 2002 - 2004 Grant Reviewer, Special Emphasis Panel, NIH
  • 2004 Member, Program Project Site Visits, NIH/NCI
  • 2005 Ad hoc Member, Subcommittee D - Clinical Studies Review Committee, NIH/NCI
  • 2005 Member, Program Project Cluster Review, NIH/NCI
  • 2005 Co-Chair, Annual Meeting Workshop, American Society of Blood and Marrow Transplantation
  • 2005 - 2007 Ad hoc Member, Cancer Immunopathology and Immunotherapy (CII) Study Section, NCI
  • 2005 Ad hoc Member, Transplantation Tolerance and Tumor Immunology (TTT) Study Section, NCI
  • 2008 Abstract Reviewer & Coordinating Reviewer, Annual Meeting, American Society of Hematology
  • 2009 - Present Representative, Federation of Clinical Immunology Societies (FOCIS), American Society for Blood and Marrow Transplantation
  • 2009 - 2013 Ad hoc Member, Cancer Immunopathology and Immunotherapy (CII) Study Section, NCI
  • 2010 - 2012 Grant Reviewer, Special Emphasis Panel, NIH
  • 2010 Ad hoc Reviewer, Children's Research Institute Pilot Innovative Research Grant Applications, Medical College of Wisconsin
  • 2011 Member, Strategic Planning "Goal A" Task Force, Society of Immunotherapy of Cancer (SITC)
  • 2011 - Present Member, ZRG1-OTC-C(2) Special Emphasis Study Section, NIH
  • 2013 Member, Cancer lmmunophathology and Immunotherapy (Cil), NCI
  • 2014 Ad hoc Reviewer, Children's Research Institute Pilot Innovative Research Grant Applications, Medical College of Wisconsin

 

Research and publications

Research

  • Optimizing Immunotherapy for Neuroblastoma after BMT, National Institutes of Health/National Cancer Institute, principal investigator, 2009-2014
  • Translational Studies of Cell-based Vaccines for Childhood Cancer, The Midwest Athletes Against Childhood Cancer Fund, co-investigator, 2007-2012
  • This is general research support awarded on an annual basis through MACC Fund contributions to the Midwest Children's Cancer Center, Midwest Athletes Against Childhood Cancer (MACC) Fund, principal investigator, 2011-2012

Publications